Ardent: Intelligently Responding to the Changing Healthcare Dynamics

Chandu Devanpally,Founder & Managing Director,  Ardent

Chandu Devanpally

Founder & Managing Director, Ardent

Indian Drug development industry has seen exponential growth in the last few years and especially in the last 1 year due to COVID-19. Now India is the global leader for COVID-19 Vaccines and has done many clinical trials for vaccine. Its not just for vaccine but there are multi trials in COVID-19 management which shows the growth in Industry. The highest number of domestic and global clinical trials was conducted in last 1 year for COVID-19 alone. No other country in the world could do this. People are now becoming aware of clinical trials and are now more keen to participate in clinical trials. "I can expect the huge growth of clinical research industry in coming years, this will hence increase the growth of the industry and ARDENT will be part of it", says Chandu Devanpally, Founder & Managing Director, Ardent.

Pune headquartered Ardent is recognized for offering the best and quality services of Clinical Trials in the Industry. Ardent Clinical Research Services is one of western India's top notch full service clinical research organizations. The firm provides end to end clinical trials services right from Study design, medical writing, clinical operations, to data management, statistical analysis and final CSR. Essentially, Ardent is one stop solution for all clinical trials.

Ardent specializes in a plethora of services including Site Management, Project Management, Monitoring, Medical Monitoring, Safety Management, Medical Writing, Complete Data Management (eCRFs), Statistical Analysis (SPSS, R-programming & SAS), Feasibility & Site selection, and Regulatory Services.

Taking Pride In Significant Studies
Evidently, Ardent has secured its position as one of the foremost Indian destination for clinical trials with its stronger research ecosystem that promotes ongoing innovation, full spectrum services, more engaged patients, higher recruitment & retention rates, better data, reduced study timelines & costs and conspicuously less time to market gap. "With our highly experienced team working around inhouse end to end clinical operations with electronic systems we are extremely competitive in the industry when it comes to services", says Pranjal Ausekar, Director Clinical Operations, Ardent.
Rightly so, from the year 2014 until today, Ardent has managed and handled various Clinical trials from Phase I to Phase IV, PMS & Observational clinical trials. The firm takes pride in having conducted studies on COVID-19 management in the year 2020 and 2021 with CSIR-IIIM Jammu, MSN Laboratory & other companies and for Molnupiravir. "We certainly looking more and more global and domestic clinical trials and we have emerged as one the best CRO in India", states Gaurav Patil, Director and Head ­ Quality Management, Ardent. Ardent is complaint with ICH-GCP, US FDA, EMEA guidelines and CT new Rules- 2019 India.

A keen strategist with the ability to understand and articulate key opportuni ties in ever changing research industry, chandu has worked on more than 15 global and domestic trials

Ardent adheres to the changing technological advancements in order to keep pace with clients' demands. Thereby, Ardent owns a software called SOURCE TRANSCRIPT, an inhouse eCRF (Electronic Case record form) and IWRS (Interactive web response system) system which are 21 CRF part 11 compliant. Inhouse services make it less time consuming and efficient to take study on board, eventually delivering the faster and reliable results.

End To End Services
Ardent also works toward addressing client's requisites with respect to deadlines. End to end services for entire clinical trial projects have been the forte of Ardent and thus, the firm is often sought for being a one stop solution for all of clients' requirements. Clients always focus on timelines of execution and completion of the project. Leveraging its large team with excellent experience, Ardent is able to execute the trial in time. Besides, the firm has a huge data base of hospitals across the country with private and government hospitals. Taking a good execution plan to its harvest, Ardent has met client's expectations with total satisfaction. Such approach has in fact, earned Ardent a plethora of esteemed clients like Glenmark pharmaceuticals, MSN laboratories, Gufic Bio sciences, Gennova Biopharmaceuticals, SAVA global, Arjuna Naturals, and SP Accure Labs etc.

As part of their future endeavors, Ardent intends to reach out to global market with multinational trials. Pertaining to this objective, the Ardent team is working on every aspect to reach to global.

Chandu Devanpally, Founder & Managing Director, Ardent
An experienced Entrepreneur, Devanpally is a meticulous, goal-oriented seasoned professional with hands on real time experience of End to End Clinical Trial Project Management, Data Management and Business Development for Clinical Trials. He holds a Post Graduation in Bio-Chemistry and Diploma in Clinical Research from Nagpur.

•Highly skilled investigators
•Deep technical expertise in diverse area of therapeutic research
•Strong IT &Data Management
•Access to ethnically diverse patient population
•Faster patient recruitment
•Cost-efficiency in trials
•High quality output
•A world class clinical support
•A favorable environment for clinical trials
•Commitment to quick Turn around Time
•Minute attention to customers requirements